Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1741-1750 of 2762 for

Edit search filters
  1. Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma

    Rochester, MN

  2. Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

    Scottsdale/Phoenix, AZ

  3. Alisertib in Treating Patients With Advanced or Metastatic Sarcoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma

    Rochester, MN

  5. Isotretinoin With or Without Monoclonal Antibody Ch14.18, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma

  6. Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery

    Rochester, MN

  7. Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors

    Rochester, MN

  8. Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia

    Scottsdale/Phoenix, AZ

  9. A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer